CN109053505A - A kind of synthetic method of Fei Luokao former times important intermediate - Google Patents
A kind of synthetic method of Fei Luokao former times important intermediate Download PDFInfo
- Publication number
- CN109053505A CN109053505A CN201810876892.XA CN201810876892A CN109053505A CN 109053505 A CN109053505 A CN 109053505A CN 201810876892 A CN201810876892 A CN 201810876892A CN 109053505 A CN109053505 A CN 109053505A
- Authority
- CN
- China
- Prior art keywords
- former times
- important intermediate
- fei luokao
- luokao former
- synthetic method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000010189 synthetic method Methods 0.000 title claims abstract description 14
- 238000006243 chemical reaction Methods 0.000 claims abstract description 35
- 239000002904 solvent Substances 0.000 claims abstract description 27
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims abstract description 14
- RJIGDHLIPFKMRP-UHFFFAOYSA-N 2-methyl-2-methylsulfonyl-1-phenylpropan-1-one Chemical compound CS(=O)(=O)C(C)(C)C(=O)C1=CC=CC=C1 RJIGDHLIPFKMRP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims abstract description 13
- 238000001953 recrystallisation Methods 0.000 claims abstract description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 48
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 27
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical group COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 17
- 238000010792 warming Methods 0.000 claims description 17
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical group NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 12
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 claims description 12
- 229940011051 isopropyl acetate Drugs 0.000 claims description 12
- 238000003786 synthesis reaction Methods 0.000 claims description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- 230000015572 biosynthetic process Effects 0.000 claims description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- 239000003054 catalyst Substances 0.000 claims description 6
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims description 5
- 239000005695 Ammonium acetate Substances 0.000 claims description 5
- 239000003513 alkali Substances 0.000 claims description 5
- 229940043376 ammonium acetate Drugs 0.000 claims description 5
- 235000019257 ammonium acetate Nutrition 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 239000002585 base Substances 0.000 claims description 4
- 239000012046 mixed solvent Substances 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 2
- BSMGLVDZZMBWQB-UHFFFAOYSA-N 2-methyl-1-phenylpropan-1-one Chemical compound CC(C)C(=O)C1=CC=CC=C1 BSMGLVDZZMBWQB-UHFFFAOYSA-N 0.000 claims 3
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 claims 3
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 235000011121 sodium hydroxide Nutrition 0.000 claims 1
- 239000000543 intermediate Substances 0.000 abstract description 24
- 150000001875 compounds Chemical class 0.000 abstract description 16
- 239000006227 byproduct Substances 0.000 abstract description 6
- 239000000047 product Substances 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 239000007858 starting material Substances 0.000 abstract description 5
- 150000003568 thioethers Chemical class 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 4
- 238000002425 crystallisation Methods 0.000 description 13
- 230000008025 crystallization Effects 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 239000000706 filtrate Substances 0.000 description 11
- 239000007787 solid Substances 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- 238000004128 high performance liquid chromatography Methods 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 238000005352 clarification Methods 0.000 description 9
- GWYFCOCPABKNJV-UHFFFAOYSA-M isovalerate Chemical compound CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 9
- 238000000926 separation method Methods 0.000 description 8
- 229910052799 carbon Inorganic materials 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 230000007062 hydrolysis Effects 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- 238000009413 insulation Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- 230000006837 decompression Effects 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- HNKJADCVZUBCPG-UHFFFAOYSA-N thioanisole Chemical compound CSC1=CC=CC=C1 HNKJADCVZUBCPG-UHFFFAOYSA-N 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- 229940126062 Compound A Drugs 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 4
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- 239000000273 veterinary drug Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 238000005893 bromination reaction Methods 0.000 description 3
- 230000000640 hydroxylating effect Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- DGMOBVGABMBZSB-UHFFFAOYSA-N 2-methylpropanoyl chloride Chemical compound CC(C)C(Cl)=O DGMOBVGABMBZSB-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical group [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 2
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 2
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Substances CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 150000001335 aliphatic alkanes Chemical group 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 230000031709 bromination Effects 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 2
- 230000003637 steroidlike Effects 0.000 description 2
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- RHDUOFVTCTUTFX-UHFFFAOYSA-N methanesulfinic acid;sodium Chemical compound [Na].CS(O)=O RHDUOFVTCTUTFX-UHFFFAOYSA-N 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 239000003444 phase transfer catalyst Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 230000006103 sulfonylation Effects 0.000 description 1
- 238000005694 sulfonylation reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
The present invention relates to a kind of synthetic methods of the intermediate of Fei Luokao former times, using to mesyl isobutyrophenone as starting material, using one kettle way, in NBS(N- bromosuccinimide) brominated intermediates are first generated under system, hydrolyze to obtain target compound [2- hydroxyl -1-(4- Metlianesulfonyl-phenyl) -2- methyl -propyl- 1- ketone] again, used material is without to the disagreeableness material of environment, it will not generate to the disagreeableness by-product of environment, such as thio-ether type compounds, it is easy to operate, without security risk, reaction condition is mild, it is suitble to industrialized production, by-product is few, and for the preferred recrystallisation solvent of target compound, it can obtain all very high product of yield and purity, it is used directly for subsequent preparation Fei Luokao former times, obtain the finished product Fei Luokao former times of high-purity.
Description
Technical field
The present invention relates to pharmaceutical chemical synthesis fields, in particular to a kind of conjunction of Fei Luokao former times important intermediate
At method.
Background technique
Fei Luokao former times is a kind of important non-steroidal anti-inflammatory veterinary drug, and effect mainly passes through selective depression epoxy
Change the synthesis for the prostaglandin that enzyme -2 (COX-2) is mediated, to block arachidonic acid to be converted into prostaglandin, and then generates solution
Heat, analgesia and anti-inflammatory effect.Compared with other non-steroidal anti-inflammatory veterinary drugs, Fei Luokao former times efficiently can selectively press down
COX-2 processed, and can be absorbed by organisms rapidly, there is significant curative effect to relief from osteoarthritis pain.
Compound 2- hydroxyl -1- (4- Metlianesulfonyl-phenyl) -2- methyl -propyl- 1- ketone, structural formula are as follows:It is
Synthesize the important intermediate of veterinary drug Fei Luokao former times.
There is following several method about the synthesis report of the intermediate at present:
Method one is patent document US5981576, and the Fei Luokao former times of US6020343A, CN1203066C report synthesizes road
Line.Using thioanisole as starting material, Friedel-Crafts reaction occurs with isobutyryl chloride and generates compound A, compound A hydroxylating generationization
Object B is closed, compound B is crystallized under ether and Hexane system after oxidant such as (OXONE ammonium persulfate-sodium bisulfate) oxidation,
Target compound C is obtained, reaction equation is as follows:
The major defect of the synthesis technology has: 1, starting material is done using the thioanisole with bad smell, in environmental protection
Aspect has very big pressure.2, hydroxylating has used carbon tetrachloride, and carbon tetrachloride is a kind of solvent, be it is known can so that
Cancer, to the solvent that human and environment is all unfavorable.3, the ether and hexane that its recrystallisation solvent is used all are extremely inflammable and explosive solvents, no
It is suitble to industrialized production.
Method two is the Fei Luokao former times synthetic route of patent document CN104803956A report.Equally it is with thioanisole
Beginning raw material occurs Friedel-Crafts reaction with isobutyryl chloride and generates compound A；Compound A is reacted with bromine again generates brominated intermediates, so
Alkali is done in sodium hydroxide afterwards, tetrabutylammonium bromide obtains compound B to hydrolyze under conditions of phase transfer catalyst；Compound B is most
After oxidant such as (OXONE ammonium persulfate-sodium bisulfate) oxidation, liquid separation is extracted, dry concentration directly obtains targeted
Close object C.Reaction equation is as follows:
The shortcomings that synthesis technology, has: 1, still starting material is done using the thioanisole with bad smell, in environmental protection
Aspect has very big pressure.2, the bromine that bromination reaction uses has extremely strong strong toxic and corrosivity, and pole is unfavorable for environment and duty
Industry health, it should avoid as far as possible using.3, the synthesis technology is that directly extractant is concentrated under reduced pressure dry to obtain target chemical combination
Object C cannot be guaranteed without the purity of suitable crystallization processes, therefore compound C.And compound C is as veterinary drug Fei Luokao
The important intermediate of former times, purity will have a direct impact on the purity of finished product Fei Luokao former times.
Method three is the Fei Luokao former times synthetic route of patent document CN107686471A report.To be starting to brom-acetophenone
Raw material occurs methylation reaction with iodomethane, produces compound a；Then with methyl sulfinic acid sodium sulfonylation occurs for compound a again
Reaction generates compound b；For solvent, NBS (i.e. N- bromo succinyl is added with DMSO (i.e. dimethyl sulfoxide) in final compound b
Imines) in 80~100 DEG C of 10~14h of reaction.Then through extraction liquid separation, dry concentration, then it is mixed in methyl tertiary butyl ether(MTBE)/normal heptane
It is crystallized under bonding solvent system, obtains target compound C.Reaction equation is as follows:
According to document " Org.lett., 2015,17,876-879 " it is found that in the synthesis technology third step compound C shape
It is as follows at mechanism:
Wherein dimethyl sulfoxide serves not only as solvent during the reaction, and also offer hydroxylating obtains oxygen source, with bromination
Intermediate state reaction generates by-product dimethyl sulphide.Dimethyl sulphide is similar with thioanisole, there is bad smell, very not friendly to environment
It is good.And dimethyl sulphide flash-point is -38 DEG C, easily combustion explosion at high heat.And the step process needs to react 10 at 80~100 DEG C
~14h, there are security risks.
Dimethyl sulphide is also the very strong reagent of nucleophilicity simultaneously, can be with bromination intermediate state under the step-length time pyroreaction
Side reaction occurs, influences the purity of compound C.The recrystallisation solvent of the technique is methyl tertiary butyl ether(MTBE)/n-heptane system, and chemical combination
Solubility of the object C in two kinds of solvents is all very poor, especially normal heptane, almost insoluble.Therefore with the mixed solvent crystallization, it is difficult
Improve the purity of compound C.
Therefore, this field is safe and environment-friendly there is still a need for one kind and can be to the synthesis side that target compound C is purified
Method, to guarantee the purity of Fei Luokao former times important intermediate, the high-purity for Fei Luokao former times provides support.
Summary of the invention
The purpose of the present invention is to provide a kind of easy to operate, production cost is low, and safe and environment-friendly, and has to non-sieve
It examines former times important intermediate to be purified, is suitble to the synthetic method of industrialized production.
The present invention provides a kind of Fei Luokao former times important intermediate, 2- hydroxyl -1- (4- Metlianesulfonyl-phenyl) -2- methyl -
The synthetic method of propyl- 1- ketone, comprising the following steps:
(1) mesyl isobutyrophenone, N-bromosuccinimide, catalyst and reaction dissolvent will be mixed, will be warming up to
60-80 DEG C of reaction, after completion of the reaction, is down to room temperature, obtains mixed liquor；
(2) aqueous alkali is added into above-mentioned mixed liquor, reacts at room temperature, after completion of the reaction, organic solvent and water is added,
Extraction, dry, filtering are concentrated under reduced pressure to get 2- hydroxyl -1- (4- Metlianesulfonyl-phenyl) -2- methyl -propyl- 1- ketone.
Reaction equation is as follows:
Using one pot reaction, the mixed liquor containing compound II that step (1) obtains is directly used in and is reacted in next step,
It is easy to operate without isolating and purifying intermediate II, high income.And the raw material used is simple and easy to get, environmentally friendly, reaction is not given birth to
The thioether class by-product influential on environment at the smell is awful.
Further, in step (1) reaction dissolvent be selected from acetonitrile, ethyl acetate or isopropyl acetate, preferably acetonitrile or
Ethyl acetate.
Further, it is 1 to the mass volume ratio (g/mL) of mesyl isobutyrophenone and reaction dissolvent in step (1):
3-6。
Further, catalyst is selected from thiocarbamide, ammonium acetate or p-methyl benzenesulfonic acid, preferably thiocarbamide or acetic acid in step (1)
Ammonium.
It further, is 1:0.1-0.5 to the molar ratio of mesyl isobutyrophenone and catalyst in step (1).
Further, to the molar ratio of mesyl isobutyrophenone and N-bromosuccinimide in step (1) are as follows: 1:
1.2-2.0。
Further, it is water-soluble to be selected from wet chemical, aqueous sodium carbonate, sodium hydroxide for the aqueous alkali of step (2)
Liquid or potassium hydroxide aqueous solution.
Further, which further includes re-crystallization step, and recrystallization solvent is selected from methyl tertiary butyl ether(MTBE), isopropyl
Alcohol, isopropyl acetate, ethyl acetate/methyl tertiary butyl ether(MTBE) mixed solvent or isopropyl acetate/methyl tertiary butyl ether(MTBE) mixed solvent.
The screening of recrystallization solvent substantially increases 2- hydroxyl -1- (4- Metlianesulfonyl-phenyl) -2- methyl -propyl- 1- ketone purity.
The present invention also provides above-mentioned preparation methods to prepare the purposes in Fei Luokao former times.
The application method applies also for compoundSynthesis, wherein R1 be Ar group, R2 be straight chain or branch
The Cn alkane group of chain, R3 are the Cn alkane group of hydrogen or linear chain or branched chain, specific such as compounds Ⅳ, V.
The Fei Luokao former times important intermediate of preparation of the embodiment of the present invention has the advantage that
(1) present invention using to mesyl isobutyrophenone as starting material, using one kettle way, in NBS (N- bromo succinyl
Imines) brominated intermediates are first generated under system, then hydrolyze to obtain target compound [2- hydroxyl -1- (4- Metlianesulfonyl-phenyl) -
2- methyl -propyl- 1- ketone], used material without to the disagreeableness material of environment, will not be generated to the disagreeableness pair of environment
Product, such as thio-ether type compounds.
(2) operation of the present invention is simple, and no security risk, reaction condition is mild, is suitble to industrialized production.
(3) by-product of the present invention is few, and for the preferred recrystallisation solvent of target compound, can obtain yield and purity
All very high product is used directly for subsequent preparation Fei Luokao former times, obtains the finished product Fei Luokao former times of high-purity.
Specific embodiment
Embodiment of the present invention is described in detail below in conjunction with embodiment, but those skilled in the art will
Understand, the following example is merely to illustrate the present invention, and is not construed as limiting the scope of the invention.
The structure of compound is nuclear magnetic resonance (1H NMR) or MS to determine.
Nuclear Magnetic Resonance (1H NMR) is Bruker AVANCE-400, and nuclear magnetic resonance (1H NMR) is displaced (δ) with million points
One of the unit of (ppm) provide, measurement solvent is DMSO-d6, is inside designated as tetramethylsilane (TMS), chemical shift is with 10-6
(ppm) it is provided as unit.
Term " room temperature " of the invention refers to that temperature is between 10-25 DEG C.
Combined with specific embodiments below, the present invention is further detailed:
The preparation of 1 Fei Luokao former times important intermediate of embodiment:
Mesyl isobutyrophenone (10.0g, 1.0eq) and 50mL acetonitrile will be mixed, it is sub- to add N- bromo succinyl
Amine (11.8g, 1.5eq), thiocarbamide (1.0g, 0.3eq) are warming up to 60~80 DEG C, and 1~2h of insulation reaction, have reacted under stirring
Entirely.It is cooled to room temperature, is then slowly added into the solution of prepared sodium hydroxide (5.0g) and water (25.0g), continues room temperature and stirs
10~12h is mixed, hydrolysis is complete.Ethyl acetate and water is added, extracts liquid separation, organic phase is dried, filtered with anhydrous sodium sulfate
Solvent is evaporated off in filtrate decompression afterwards, and 20mL isopropanol is then added, is warming up to 70 DEG C, and at the uniform velocity cool down crystallization after dissolved clarification, filters, dry
Obtain 2- hydroxyl -1- (4- Metlianesulfonyl-phenyl) -2- methyl -propyl- 1- ketone.(9.18g, light tan solid, yield 85.7%,
98.1%) HPLC purity is.
The characterization result of Fei Luokao former times important intermediate provided in this embodiment is as follows:
1HNMR (CDCl3) δ 1.61 (6H, s), δ 3.09 (3H, s), δ 3.32 (1H, br), δ 8.02-8.00 (2H, m), δ
8.22-8.19 (2H, m)
LC-MS: the intermediate molecule amount is 242.29, and mass spectrum gives the peak [M+H] ﹢, and m/z 243.2 meets its molecule
Amount.
The preparation of 2 Fei Luokao former times important intermediate of embodiment:
Mesyl isobutyrophenone (30.0g, 1.0eq) and 90mL acetonitrile will be mixed, it is sub- to add N- bromo succinyl
Amine (37.8g, 1.6eq), thiocarbamide (2.0g, 0.2eq) are warming up to 60~80 DEG C, and 1~2h of insulation reaction, have reacted under stirring
Entirely.It is cooled to room temperature, is then slowly added into the solution of prepared sodium hydroxide (15.0g) and water (75.0g), continues room temperature and stirs
10~12h is mixed, hydrolysis is complete.Ethyl acetate and water is added, extracts liquid separation, organic phase is dried, filtered with anhydrous sodium sulfate
Solvent is evaporated off in filtrate decompression afterwards, and 45mL isopropyl acetate is then added, is warming up to 75 DEG C, and at the uniform velocity cool down crystallization after dissolved clarification, filtering,
It is dried to obtain 2- hydroxyl -1- (4- Metlianesulfonyl-phenyl) -2- methyl -propyl- 1- ketone.(28.0g, light tan solid, yield
98.8%) 87.2%, HPLC purity are.
The preparation of 3 Fei Luokao former times important intermediate of embodiment:
Mesyl isobutyrophenone (30.0g, 1.0eq) and 150mL acetonitrile will be mixed, it is sub- to add N- bromo succinyl
Amine (37.8g, 1.6eq), ammonium acetate (2.0g, 0.2eq) are warming up to 60~80 DEG C, and 1~2h of insulation reaction under stirring, reaction
Completely.It is cooled to room temperature, is then slowly added into the solution of prepared potassium hydroxide (21.0g) and water (105.0g), continues room
Temperature 10~12h of stirring, hydrolysis are complete.Ethyl acetate and water is added, extracts liquid separation, organic phase is dry with anhydrous sodium sulfate,
Solvent is evaporated off in filtrate decompression after filtering, and 45mL isopropyl acetate is then added, is warming up to 75 DEG C, and at the uniform velocity cool down crystallization after dissolved clarification,
Filtering, is dried to obtain 2- hydroxyl -1- (4- Metlianesulfonyl-phenyl) -2- methyl -propyl- 1- ketone.(27.4g, light tan solid, yield
98.5%) 85.3%, HPLC purity are.
The preparation of 4 Fei Luokao former times important intermediate of embodiment:
Mesyl isobutyrophenone (10.0g, 1.0eq) and 50mL ethyl acetate will be mixed, and add N- bromo amber
Acid imide (9.4g, 1.2eq), thiocarbamide (1.7g, 0.5eq) are warming up to 60~80 DEG C, and 1~2h of insulation reaction under stirring, reaction
Completely.It is cooled to room temperature, is then slowly added into the solution of prepared sodium carbonate (10.0g) and water (50.0g), continues room temperature and stirs
10~12h is mixed, hydrolysis is complete.Ethyl acetate and water is added, extracts liquid separation, organic phase is dried, filtered with anhydrous sodium sulfate
Solvent is evaporated off in filtrate decompression afterwards, and 10mL isopropyl acetate is then added, is warming up to 75 DEG C, and at the uniform velocity cool down crystallization after dissolved clarification, filtering,
It is dried to obtain 2- hydroxyl -1- (4- Metlianesulfonyl-phenyl) -2- methyl -propyl- 1- ketone.(28.0g, light tan solid, yield
97.3%) 85.7%, HPLC purity are.
The preparation of 5 Fei Luokao former times important intermediate of embodiment:
Mesyl isobutyrophenone (10.0g, 1.0eq) and 60mL acetonitrile will be mixed, it is sub- to add N- bromo succinyl
Amine (15.7g, 2.0eq), thiocarbamide (0.34g, 0.1eq) are warming up to 60~80 DEG C, and 1~2h of insulation reaction, have reacted under stirring
Entirely.It is cooled to room temperature, the solution of prepared potassium carbonate (10.0g) and water (50.0g) is then slowly added into, continues to be stirred at room temperature
10~12h, hydrolysis are complete.Ethyl acetate and water is added, liquid separation is extracted, after organic phase is dried, filtered with anhydrous sodium sulfate
Solvent is evaporated off in filtrate decompression, and 15mL isopropyl acetate is then added, is warming up to 75 DEG C, and at the uniform velocity cool down crystallization after dissolved clarification, filters, and does
It is dry to obtain 2- hydroxyl -1- (4- Metlianesulfonyl-phenyl) -2- methyl -propyl- 1- ketone.(9.1g, light tan solid, yield 85.0%,
97.2%) HPLC purity is.
The preparation of 6 Fei Luokao former times important intermediate of embodiment:
Mesyl isobutyrophenone (50.0g, 1.0eq) and 250mL acetonitrile will be mixed, it is sub- to add N- bromo succinyl
Amine (62.9g, 1.6eq), ammonium acetate (3.4g, 0.2eq) are warming up to 60~80 DEG C, and 1~2h of insulation reaction under stirring, reaction
Completely.It is cooled to room temperature, is then slowly added into the solution of prepared sodium hydroxide (20.0g) and water (100.0g), continues room
Temperature 10~12h of stirring, hydrolysis are complete.Ethyl acetate and water is added, extracts liquid separation, organic phase is dry with anhydrous sodium sulfate,
Filtrate is divided into five parts by quality after filtering, tests different recrystallisation solvents respectively:
Take first part of filtrate, then 10mL isopropyl acetate is added in evaporating solvent under reduced pressure, be warming up to 75 DEG C, even after dissolved clarification
Prompt drop temperature crystallization, filtering, is dried to obtain 2- hydroxyl -1- (4- Metlianesulfonyl-phenyl) -2- methyl -propyl- 1- ketone.(9.45g, shallow palm fibre
97.7%) color solid, yield 88.3%, HPLC purity are.
Second part of filtrate is taken, then evaporating solvent under reduced pressure is added 15mL methyl tertiary butyl ether(MTBE), is warming up to 55 DEG C, after dissolved clarification
At the uniform velocity cool down crystallization, and filtering is dried to obtain 2- hydroxyl -1- (4- Metlianesulfonyl-phenyl) -2- methyl -propyl- 1- ketone.(9.63g, shallowly
96.5%) brown solid, yield 89.9%, HPLC purity are.
Third part filtrate is taken, then 15mL methyl tertiary butyl ether(MTBE) and 5mL ethyl acetate, heating is added in evaporating solvent under reduced pressure
To 60 DEG C, at the uniform velocity cool down crystallization after dissolved clarification, filtering, be dried to obtain 2- hydroxyl -1- (4- Metlianesulfonyl-phenyl) -2- methyl -propyl-
1- ketone.(97.4%) 9.20g, light tan solid, yield 85.9%, HPLC purity are.
The 4th part of filtrate is taken, then 15mL methyl tertiary butyl ether(MTBE) and 5mL isopropyl acetate is added in evaporating solvent under reduced pressure, rise
Temperature is to 60 DEG C, and at the uniform velocity cool down crystallization after dissolved clarification, and filtering is dried to obtain 2- hydroxyl -1- (4- Metlianesulfonyl-phenyl) -2- methyl -
Propyl- 1- ketone.(96.9%) 9.31g, light tan solid, yield 87.0%, HPLC purity are.
The 5th part of filtrate is taken, then evaporating solvent under reduced pressure is added 10mL ethyl acetate and is warming up to 70 DEG C, is at the uniform velocity added dropwise to
5mL normal heptane.Then at the uniform velocity cool down crystallization, filtering, be dried to obtain 2- hydroxyl -1- (4- Metlianesulfonyl-phenyl) -2- methyl -propyl-
1- ketone.(92.6%) 9.46g, light tan solid, yield 88.4%, HPLC purity are.
Comparative example 1 is prepared according to method disclosed in Chinese patent CN107686471A embodiment 10.
B1 (40.0g, 1.0eq) is dissolved in 200mL dimethyl sulfoxide, add N-bromosuccinimide (6.3g,
0.2eq).It is warming up to 100 DEG C of reaction 12h.It is cooled to room temperature after fully reacting, ethyl acetate and water extraction is added, it is organic relevant
It is dry, with methyl tertiary butyl ether(MTBE)-normal heptane crystallization after evaporating solvent under reduced pressure, obtain compound C, it may be assumed that 2- hydroxy-2-methyl-(4- first
Base sulfonyl) phenyl -1- acetone, (35.4g, yield 82.7%, faint yellow solid, purity 92.1%).
By above-mentioned experiment it is found that 2- hydroxy-2-methyl-(4- methyl sulphonyl) phenyl-that 1-6 of the embodiment of the present invention is provided
The preparation method of 1- acetone, yield are slightly above comparative example 1, and purity is apparently higher than comparative example 1, and preparation of the invention
Method does not generate the thioether class by-product influential on environment that the smell is awful, and comparative example 1 generates the diformazan that the smell is awful
Thioether.
The foregoing is only a preferred embodiment of the present invention, is not intended to restrict the invention, for the skill of this field
For art personnel, the invention may be variously modified and varied.All within the spirits and principles of the present invention, made any to repair
Change, equivalent replacement, improvement etc., should all be included in the protection scope of the present invention.
Claims (10)
1. a kind of synthetic method of Fei Luokao former times important intermediate, comprising the following steps:
(1) mesyl isobutyrophenone, N-bromosuccinimide, catalyst and reaction dissolvent will be mixed, and will be warming up to 60-80
DEG C reaction, after completion of the reaction, be down to room temperature, obtain mixed liquor；
(2) aqueous alkali is added into above-mentioned mixed liquor, reacts at room temperature, after completion of the reaction, organic solvent and water, extraction is added
It takes, dry, filtering is concentrated under reduced pressure to get 2- hydroxyl -1- (4- Metlianesulfonyl-phenyl) -2- methyl -propyl- 1- ketone；
Reaction equation is as follows:
2. the synthetic method of Fei Luokao former times important intermediate according to claim 1, which is characterized in that the reaction dissolvent
Selected from acetonitrile, ethyl acetate or isopropyl acetate.
3. the synthetic method of Fei Luokao former times important intermediate according to claim 2, which is characterized in that the reaction dissolvent
For acetonitrile or ethyl acetate.
4. the synthetic method of Fei Luokao former times important intermediate according to claim 2, which is characterized in that described to methylsulfonyl
The mass volume ratio (g/mL) of base isobutyrophenone and the reaction dissolvent is 1:3-6.
5. the synthetic method of Fei Luokao former times important intermediate according to claim 1-4, which is characterized in that described
Catalyst is selected from thiocarbamide, ammonium acetate or p-methyl benzenesulfonic acid, preferably thiocarbamide or ammonium acetate.
6. the synthetic method of Fei Luokao former times important intermediate according to claim 1, which is characterized in that described to methylsulfonyl
The molar ratio of base isobutyrophenone and catalyst is 1:0.1-0.5.
7. the synthetic method of Fei Luokao former times important intermediate according to claim 1, which is characterized in that described to methylsulfonyl
The molar ratio of base isobutyrophenone and N-bromosuccinimide are as follows: 1:1.2-2.0.
8. the synthetic method of Fei Luokao former times important intermediate according to claim 1, which is characterized in that the step (2)
Aqueous alkali be selected from wet chemical, aqueous sodium carbonate, sodium hydrate aqueous solution or potassium hydroxide aqueous solution.
9. the synthetic method of Fei Luokao former times important intermediate according to claim 1, which is characterized in that further include recrystallization
Step, it is molten that recrystallization solvent is selected from methyl tertiary butyl ether(MTBE), isopropanol, isopropyl acetate, ethyl acetate/methyl tertiary butyl ether(MTBE) mixing
Agent or isopropyl acetate/methyl tertiary butyl ether(MTBE) mixed solvent.
10. purposes of the preparation method described in any one of claim 1-9 in synthesis Fei Luokao former times.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810876892.XA CN109053505B (en) | 2018-08-03 | 2018-08-03 | Synthesis method of important intermediate of feloxicib |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810876892.XA CN109053505B (en) | 2018-08-03 | 2018-08-03 | Synthesis method of important intermediate of feloxicib |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN109053505A true CN109053505A (en) | 2018-12-21 |
| CN109053505B CN109053505B (en) | 2020-08-11 |
Family
ID=64833149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810876892.XA Active CN109053505B (en) | 2018-08-03 | 2018-08-03 | Synthesis method of important intermediate of feloxicib |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109053505B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110452198A (en) * | 2019-09-03 | 2019-11-15 | 山东鲁抗舍里乐药业有限公司 | A kind of preparation method of Fei Luokao former times |
| CN110452199A (en) * | 2019-09-03 | 2019-11-15 | 山东鲁抗舍里乐药业有限公司 | A kind of preparation method of Fei Luokao former times |
| CN112500321A (en) * | 2020-09-25 | 2021-03-16 | 安徽省公众检验研究院有限公司 | Preparation method of feloxicib key intermediate |
| CN112624943A (en) * | 2020-12-28 | 2021-04-09 | 成都伊诺达博医药科技有限公司 | Synthesis method of feloxicib intermediate |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6020343A (en) * | 1995-10-13 | 2000-02-01 | Merck Frosst Canada, Inc. | (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors |
| US20030225098A1 (en) * | 2002-03-21 | 2003-12-04 | Hirst Gavin C. | Kinase inhibitors |
| CN104803956A (en) * | 2015-03-06 | 2015-07-29 | 江苏天和制药有限公司 | Synthesis method of firocoxib |
| CN106349285A (en) * | 2016-08-29 | 2017-01-25 | 天津久日新材料股份有限公司 | Hydroxyl-containing acyl phosphine oxides and their preparation and application |
| CN107686471A (en) * | 2017-09-28 | 2018-02-13 | 四川青木制药有限公司 | A kind of Fei Luokao former times and its synthetic method of intermediate |
| US20180044284A1 (en) * | 2016-08-12 | 2018-02-15 | International Business Machines Corporation | Non-ionic low diffusing photo-acid generators |
-
2018
- 2018-08-03 CN CN201810876892.XA patent/CN109053505B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6020343A (en) * | 1995-10-13 | 2000-02-01 | Merck Frosst Canada, Inc. | (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors |
| US20030225098A1 (en) * | 2002-03-21 | 2003-12-04 | Hirst Gavin C. | Kinase inhibitors |
| CN104803956A (en) * | 2015-03-06 | 2015-07-29 | 江苏天和制药有限公司 | Synthesis method of firocoxib |
| US20180044284A1 (en) * | 2016-08-12 | 2018-02-15 | International Business Machines Corporation | Non-ionic low diffusing photo-acid generators |
| CN106349285A (en) * | 2016-08-29 | 2017-01-25 | 天津久日新材料股份有限公司 | Hydroxyl-containing acyl phosphine oxides and their preparation and application |
| CN107686471A (en) * | 2017-09-28 | 2018-02-13 | 四川青木制药有限公司 | A kind of Fei Luokao former times and its synthetic method of intermediate |
Non-Patent Citations (2)
| Title |
|---|
| BOVONSOMBAT, PAKORN等: "Regioselective monobromination of aromatics via a halogen bond acceptor-donor interaction of catalytic thioamide and N-bromosuccinimide", 《TETRAHEDRON》 * |
| DAS, BISWANATH 等: "Studies on novel synthetic methodologies. Part 116. A facile nuclear bromination of phenols and anilines using NBS in the presence of ammonium acetate as a catalyst", 《JOURNAL OF MOLECULAR CATALYSIS A: CHEMICAL》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110452198A (en) * | 2019-09-03 | 2019-11-15 | 山东鲁抗舍里乐药业有限公司 | A kind of preparation method of Fei Luokao former times |
| CN110452199A (en) * | 2019-09-03 | 2019-11-15 | 山东鲁抗舍里乐药业有限公司 | A kind of preparation method of Fei Luokao former times |
| CN112500321A (en) * | 2020-09-25 | 2021-03-16 | 安徽省公众检验研究院有限公司 | Preparation method of feloxicib key intermediate |
| CN112624943A (en) * | 2020-12-28 | 2021-04-09 | 成都伊诺达博医药科技有限公司 | Synthesis method of feloxicib intermediate |
| CN112624943B (en) * | 2020-12-28 | 2022-07-01 | 成都伊诺达博医药科技有限公司 | Synthesis method of feloxicib intermediate |
Also Published As
| Publication number | Publication date |
|---|---|
| CN109053505B (en) | 2020-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109053505A (en) | A kind of synthetic method of Fei Luokao former times important intermediate | |
| CN107686471B (en) | Synthesis method of feloxicib and intermediate thereof | |
| TW201309663A (en) | 3-hydroxy-6H-benzo-(c) chromene-6-one derivative and producing method thereof | |
| CN106536479B (en) | The method for being used to prepare beta-amino sulphones | |
| EP1845084B1 (en) | Process for producing (z)-1-phenyl-1-(n,n-diethylaminocarbonyl)idomethylcyclopropane | |
| CN107540598A (en) | A kind of method for preparing N difluoro methyl mercapto neighbour's benzoylimino class compounds | |
| CN108586399A (en) | A kind of synthetic method of Fei Luokao former times | |
| CN113286783B (en) | Method for producing chlorobenzene compounds | |
| CN111170837B (en) | Synthesis method of methyl ketone compound | |
| AU2006274461A1 (en) | Process for the production of bicalutamide | |
| US8586792B2 (en) | Process for the preparation of 4-iodo-3-nitrobenzamide | |
| US7282610B2 (en) | Method of producing aromatic amine compound having alkylthio group | |
| JPH03258760A (en) | Method for separating diphenylsulfone derivative | |
| JP2655359B2 (en) | Synthesis of aromatic amines, aromatic alcohols and aromatic thiols by aromatic nucleophilic substitution reaction | |
| US7329779B2 (en) | Process for preparing optionally substituted arylsulphonic anhydrides | |
| JP7628505B2 (en) | Method for producing 4-(aminomethyl)cyclohexanecarboxylic acid | |
| JPH0753513A (en) | Method for producing N-substituted maleimide | |
| KR100345464B1 (en) | Method for preparing 2-(2'-chloroethylsulfonyl)ethylamine HCl salt | |
| CN114835643A (en) | Preparation method of amide compound | |
| CN116199605A (en) | Synthesis method of 5-chloro-2-hydroxy-dimethylbenzenesulfonamide | |
| JPS6348260A (en) | Production of alkali metallic salt of benzenesulfinic acid | |
| CN111825581A (en) | Method for synthesizing trifluoromethylthio compound with trifluoromethylsulfinyl chloride | |
| JPH024784A (en) | Production of 5-amino-6-fluoro-2-benzothiazolone | |
| Li et al. | An efficient synthesis of Ecopladib | |
| CN111205188A (en) | Process for producing cycloalkane compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |